Drug
Ceftazidime
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hyperbilirubinaemia | 113 | 30.5 | 30.9 | signal |
| 2 | Toxic Epidermal Necrolysis | 121 | 22.2 | 22.6 | signal |
| 3 | Septic Shock | 341 | 21.8 | 22.8 | signal |
| 4 | Mucosal Inflammation | 183 | 19.4 | 19.9 | signal |
| 5 | Drug Resistance | 177 | 19.1 | 19.5 | signal |
| 6 | Clostridium Difficile Colitis | 72 | 18.7 | 18.9 | signal |
| 7 | Multiple Organ Dysfunction Syndrome | 186 | 18.4 | 18.9 | signal |
| 8 | Disseminated Intravascular Coagulation | 94 | 18.4 | 18.6 | signal |
| 9 | Renal Tubular Necrosis | 62 | 17.4 | 17.6 | signal |
| 10 | Drug Reaction With Eosinophilia And Systemic Symptoms | 157 | 17.0 | 17.3 | signal |
| 11 | Multi-organ Failure | 94 | 14.8 | 15.0 | signal |
| 12 | Intraocular Pressure Increased | 67 | 14.4 | 14.5 | signal |
| 13 | Eosinophilia | 89 | 14.1 | 14.2 | signal |
| 14 | Cholestasis | 97 | 14.0 | 14.2 | signal |
| 15 | Uveitis | 68 | 13.9 | 14.0 | signal |
| 16 | Rash Maculo-papular | 111 | 13.8 | 14.0 | signal |
| 17 | Toxic Skin Eruption | 49 | 13.4 | 13.5 | signal |
| 18 | Generalised Oedema | 56 | 12.5 | 12.6 | signal |
| 19 | Candida Infection | 75 | 12.4 | 12.5 | signal |
| 20 | Febrile Neutropenia | 273 | 11.4 | 11.8 | signal |
| 21 | Bacteraemia | 47 | 11.0 | 11.1 | signal |
| 22 | Peritonitis Bacterial | 39 | 10.7 | 10.7 | signal |
| 23 | Transfusion | 40 | 10.5 | 10.5 | signal |
| 24 | Status Epilepticus | 43 | 10.5 | 10.5 | signal |
| 25 | Abscess | 59 | 10.2 | 10.3 | signal |
| 26 | Nerve Compression | 34 | 10.2 | 10.2 | signal |
| 27 | Respiratory Failure | 260 | 9.8 | 10.1 | signal |
| 28 | Cytomegalovirus Infection | 58 | 9.6 | 9.7 | signal |
| 29 | Peritonitis | 72 | 9.6 | 9.7 | signal |
| 30 | Acute Respiratory Distress Syndrome | 61 | 9.5 | 9.6 | signal |
| 31 | Myoclonus | 41 | 9.5 | 9.5 | signal |
| 32 | Bacterial Infection | 62 | 9.2 | 9.3 | signal |
| 33 | Hepatic Cytolysis | 40 | 9.0 | 9.1 | signal |
| 34 | Hepatocellular Injury | 46 | 8.9 | 9.0 | signal |
| 35 | Pancytopenia | 179 | 8.8 | 9.0 | signal |
| 36 | Ascites | 94 | 8.8 | 8.9 | signal |
| 37 | Hepatomegaly | 31 | 8.6 | 8.7 | signal |
| 38 | Neurotoxicity | 54 | 8.6 | 8.6 | signal |
| 39 | Blood Bilirubin Increased | 84 | 8.5 | 8.6 | signal |
| 40 | Gamma-glutamyltransferase Increased | 68 | 8.4 | 8.5 | signal |
| 41 | Shock | 69 | 8.3 | 8.4 | signal |
| 42 | Adrenal Insufficiency | 36 | 8.3 | 8.3 | signal |
| 43 | Pneumocystis Jirovecii Pneumonia | 30 | 8.3 | 8.3 | signal |
| 44 | Device Related Infection | 46 | 8.2 | 8.3 | signal |
| 45 | Renal Failure Acute | 127 | 8.1 | 8.2 | signal |
| 46 | Respiratory Distress | 79 | 7.9 | 7.9 | signal |
| 47 | Encephalopathy | 70 | 7.9 | 7.9 | signal |
| 48 | Blood Urea Increased | 47 | 7.7 | 7.7 | signal |
| 49 | Visual Acuity Reduced | 93 | 7.6 | 7.7 | signal |
| 50 | Acute Respiratory Failure | 53 | 7.6 | 7.7 | signal |
| 51 | Tubulointerstitial Nephritis | 51 | 7.5 | 7.5 | signal |
| 52 | Blood Alkaline Phosphatase Increased | 67 | 7.4 | 7.5 | signal |
| 53 | Injection Site Extravasation | 32 | 7.1 | 7.1 | signal |
| 54 | Lymphopenia | 36 | 7.0 | 7.1 | signal |
| 55 | C-reactive Protein Increased | 92 | 7.0 | 7.0 | signal |
| 56 | Nephropathy Toxic | 28 | 6.9 | 6.9 | signal |
| 57 | Bone Marrow Failure | 50 | 6.7 | 6.8 | signal |
| 58 | Electrolyte Imbalance | 28 | 6.7 | 6.7 | signal |
| 59 | Cytopenia | 29 | 6.7 | 6.7 | signal |
| 60 | Hypoxia | 85 | 6.7 | 6.7 | signal |
| 61 | Neutropenia | 327 | 6.6 | 6.9 | signal |
| 62 | Sepsis | 269 | 6.6 | 6.8 | signal |
| 63 | Stevens-johnson Syndrome | 53 | 6.5 | 6.6 | signal |
| 64 | Thrombotic Microangiopathy | 23 | 6.5 | 6.6 | signal |
| 65 | Cytokine Release Syndrome | 45 | 6.5 | 6.5 | signal |
| 66 | Hypokalaemia | 108 | 6.5 | 6.6 | signal |
| 67 | Staphylococcal Infection | 77 | 6.4 | 6.5 | signal |
| 68 | Clostridium Difficile Infection | 49 | 6.2 | 6.3 | signal |
| 69 | Hepatic Failure | 67 | 6.1 | 6.1 | signal |
| 70 | Leukopenia | 110 | 6.1 | 6.1 | signal |
| 71 | Melaena | 48 | 6.0 | 6.0 | signal |
| 72 | Blood Lactate Dehydrogenase Increased | 34 | 5.9 | 5.9 | signal |
| 73 | Renal Impairment | 178 | 5.9 | 6.0 | signal |
| 74 | Neutrophil Count Decreased | 86 | 5.8 | 5.9 | signal |
| 75 | Drug Ineffective For Unapproved Indication | 117 | 5.8 | 5.8 | signal |
| 76 | Hypomagnesaemia | 29 | 5.8 | 5.8 | signal |
| 77 | Acute Kidney Injury | 318 | 5.7 | 6.0 | signal |
| 78 | Thrombocytopenia | 229 | 5.7 | 5.8 | signal |
| 79 | Hepatic Function Abnormal | 76 | 5.6 | 5.7 | signal |
| 80 | Alanine Aminotransferase Increased | 125 | 5.6 | 5.7 | signal |
| 81 | Folliculitis | 21 | 5.6 | 5.6 | signal |
| 82 | Eye Pain | 111 | 5.5 | 5.6 | signal |
| 83 | Agranulocytosis | 37 | 5.5 | 5.5 | signal |
| 84 | Tachypnoea | 27 | 5.5 | 5.5 | signal |
| 85 | Leukocytosis | 36 | 5.5 | 5.5 | signal |
| 86 | Lymphocyte Count Decreased | 35 | 5.4 | 5.5 | signal |
| 87 | Petechiae | 20 | 5.3 | 5.3 | signal |
| 88 | Increased Appetite | 36 | 5.3 | 5.3 | signal |
| 89 | Myelosuppression | 65 | 5.3 | 5.3 | signal |
| 90 | Hypocalcaemia | 36 | 5.2 | 5.3 | signal |
| 91 | Fungal Infection | 61 | 5.0 | 5.1 | signal |
| 92 | Posterior Reversible Encephalopathy Syndrome | 17 | 4.9 | 4.9 | signal |
| 93 | Aspartate Aminotransferase Increased | 94 | 4.9 | 4.9 | signal |
| 94 | Oral Candidiasis | 23 | 4.9 | 4.9 | signal |
| 95 | Pleural Effusion | 107 | 4.8 | 4.9 | signal |
| 96 | Sinus Bradycardia | 17 | 4.8 | 4.8 | signal |
| 97 | Atelectasis | 17 | 4.8 | 4.8 | signal |
| 98 | Acute Myeloid Leukaemia | 27 | 4.8 | 4.8 | signal |
| 99 | Hyperkalaemia | 60 | 4.7 | 4.8 | signal |
| 100 | Delirium | 59 | 4.7 | 4.7 | signal |
| 101 | Metabolic Acidosis | 54 | 4.7 | 4.7 | signal |
| 102 | Sinus Tachycardia | 24 | 4.7 | 4.7 | signal |
| 103 | Electrocardiogram Qt Prolonged | 60 | 4.6 | 4.6 | signal |
| 104 | Pneumothorax | 26 | 4.5 | 4.5 | signal |
| 105 | Drug Level Increased | 27 | 4.5 | 4.5 | signal |
| 106 | Cardiogenic Shock | 23 | 4.4 | 4.4 | signal |
| 107 | Intervertebral Disc Protrusion | 35 | 4.4 | 4.4 | signal |
| 108 | Brain Oedema | 20 | 4.4 | 4.4 | signal |
| 109 | Gastroenteritis | 23 | 4.3 | 4.4 | signal |
| 110 | Transaminases Increased | 35 | 4.3 | 4.3 | signal |
| 111 | Pancreatitis Acute | 35 | 4.3 | 4.3 | signal |
| 112 | Pyrexia | 542 | 4.3 | 4.6 | signal |
| 113 | Ileus | 19 | 4.2 | 4.3 | signal |
| 114 | Hypercalcaemia | 19 | 4.2 | 4.2 | signal |
| 115 | No Therapeutic Response | 19 | 4.2 | 4.2 | signal |
| 116 | Drug Eruption | 27 | 4.2 | 4.2 | signal |
| 117 | Ventricular Fibrillation | 17 | 4.2 | 4.2 | signal |
| 118 | Pneumonia Aspiration | 38 | 4.2 | 4.2 | signal |
| 119 | Blood Creatinine Increased | 98 | 4.1 | 4.2 | signal |
| 120 | Coma | 70 | 4.0 | 4.1 | signal |
| 121 | Drug-induced Liver Injury | 45 | 4.0 | 4.0 | signal |
| 122 | Premature Baby | 44 | 4.0 | 4.0 | signal |
| 123 | Liver Injury | 35 | 4.0 | 4.0 | signal |
| 124 | Malnutrition | 16 | 4.0 | 4.0 | signal |
| 125 | Blood Potassium Decreased | 43 | 3.9 | 3.9 | signal |
| 126 | Platelet Count Decreased | 152 | 3.9 | 4.0 | signal |
| 127 | Retinal Detachment | 13 | 3.9 | 3.9 | signal |
| 128 | Pneumonitis | 38 | 3.9 | 3.9 | signal |
| 129 | Haematotoxicity | 13 | 3.9 | 3.9 | signal |
| 130 | Acute Hepatic Failure | 19 | 3.8 | 3.8 | signal |
| 131 | Bronchospasm | 20 | 3.8 | 3.8 | signal |
| 132 | Hypotonia | 14 | 3.8 | 3.8 | signal |
| 133 | Eye Inflammation | 13 | 3.8 | 3.8 | signal |
| 134 | Renal Failure | 183 | 3.8 | 3.8 | signal |
| 135 | Splenomegaly | 16 | 3.8 | 3.8 | signal |
| 136 | Obstructive Airways Disorder | 15 | 3.7 | 3.7 | signal |
| 137 | Hypotension | 269 | 3.7 | 3.8 | signal |
| 138 | Hyponatraemia | 75 | 3.7 | 3.7 | signal |
| 139 | Pulmonary Fibrosis | 25 | 3.6 | 3.6 | signal |
| 140 | Diverticulitis | 36 | 3.6 | 3.6 | signal |
| 141 | Altered State Of Consciousness | 28 | 3.6 | 3.6 | signal |
| 142 | Liver Function Test Abnormal | 38 | 3.6 | 3.6 | signal |
| 143 | Jaundice | 35 | 3.6 | 3.6 | signal |
| 144 | Haematuria | 44 | 3.5 | 3.5 | signal |
| 145 | Hypothermia | 13 | 3.5 | 3.5 | signal |
| 146 | Drug Level Decreased | 13 | 3.5 | 3.5 | signal |
| 147 | Cyanosis | 20 | 3.5 | 3.5 | signal |
| 148 | Cholecystitis | 15 | 3.5 | 3.5 | signal |
| 149 | Urinary Retention | 42 | 3.5 | 3.5 | signal |
| 150 | Lung Disorder | 60 | 3.4 | 3.4 | signal |
| 151 | Cardiomyopathy | 18 | 3.3 | 3.3 | signal |
| 152 | Haemoptysis | 34 | 3.3 | 3.4 | signal |
| 153 | Hypoglycaemia | 59 | 3.3 | 3.4 | signal |
| 154 | Ventricular Tachycardia | 20 | 3.3 | 3.3 | signal |
| 155 | Productive Cough | 57 | 3.3 | 3.3 | signal |
| 156 | Coagulopathy | 20 | 3.3 | 3.3 | signal |
| 157 | Rash Erythematous | 56 | 3.3 | 3.3 | signal |
| 158 | Diarrhoea Haemorrhagic | 11 | 3.2 | 3.2 | signal |
| 159 | Blood Potassium Increased | 19 | 3.2 | 3.2 | signal |
| 160 | Hypertensive Crisis | 13 | 3.2 | 3.2 | signal |
| 161 | Drug Toxicity | 16 | 3.2 | 3.2 | signal |
| 162 | Ejection Fraction Decreased | 18 | 3.2 | 3.2 | signal |
| 163 | Anaemia | 219 | 3.2 | 3.2 | signal |
| 164 | Stomatitis | 69 | 3.1 | 3.1 | signal |
| 165 | Hepatotoxicity | 25 | 3.1 | 3.1 | signal |
| 166 | Premature Delivery | 18 | 3.1 | 3.1 | signal |
| 167 | Condition Aggravated | 336 | 3.1 | 3.2 | signal |
| 168 | Interstitial Lung Disease | 53 | 3.0 | 3.0 | signal |
| 169 | Covid-19 Pneumonia | 13 | 3.0 | 3.0 | signal |
| 170 | Pulmonary Oedema | 49 | 3.0 | 3.0 | signal |
| 171 | Ataxia | 13 | 3.0 | 3.0 | signal |
| 172 | Pericardial Effusion | 25 | 3.0 | 3.0 | signal |
| 173 | Mental Status Changes | 30 | 3.0 | 3.0 | signal |
| 174 | Hepatic Encephalopathy | 10 | 2.9 | 2.9 | signal |
| 175 | White Blood Cell Count Decreased | 116 | 2.9 | 3.0 | signal |
| 176 | Drug Interaction | 169 | 2.9 | 3.0 | signal |
| 177 | Blood Calcium Decreased | 12 | 2.9 | 2.9 | signal |
| 178 | Sputum Discoloured | 10 | 2.9 | 2.9 | signal |
| 179 | Hemiparesis | 18 | 2.9 | 2.9 | signal |
| 180 | Osteomyelitis | 19 | 2.9 | 2.9 | signal |
| 181 | Supraventricular Tachycardia | 10 | 2.9 | 2.9 | signal |
| 182 | Vitreous Floaters | 10 | 2.8 | 2.8 | signal |
| 183 | Cardiac Arrest | 85 | 2.8 | 2.8 | signal |
| 184 | Tachycardia | 91 | 2.8 | 2.8 | signal |
| 185 | Acute Myocardial Infarction | 30 | 2.8 | 2.8 | signal |
| 186 | Pulmonary Mass | 15 | 2.8 | 2.8 | signal |
| 187 | Cardiac Failure | 80 | 2.7 | 2.8 | signal |
| 188 | Platelet Count Increased | 13 | 2.7 | 2.7 | signal |
| 189 | Herpes Zoster | 57 | 2.7 | 2.7 | signal |
| 190 | Sleep Disorder Due To A General Medical Condition | 16 | 2.7 | 2.7 | signal |
| 191 | Tooth Abscess | 10 | 2.7 | 2.7 | signal |
| 192 | Disease Progression | 115 | 2.7 | 2.7 | signal |
| 193 | Hyperglycaemia | 35 | 2.6 | 2.7 | signal |
| 194 | Lung Infection | 15 | 2.6 | 2.6 | signal |
| 195 | Haematocrit Decreased | 19 | 2.6 | 2.6 | signal |
| 196 | Foetal Exposure During Pregnancy | 77 | 2.6 | 2.6 | signal |
| 197 | Therapy Non-responder | 42 | 2.6 | 2.6 | signal |
| 198 | Anaphylactic Shock | 24 | 2.6 | 2.6 | signal |
| 199 | Pneumonia | 301 | 2.6 | 2.6 | signal |
| 200 | Oedema | 50 | 2.5 | 2.5 | signal |
| 201 | End Stage Renal Disease | 17 | 2.5 | 2.5 | signal |
| 202 | Product Preparation Error | 19 | 2.5 | 2.5 | signal |
| 203 | Dialysis | 13 | 2.5 | 2.5 | signal |
| 204 | Therapeutic Response Decreased | 55 | 2.5 | 2.5 | signal |
| 205 | Mouth Ulceration | 19 | 2.5 | 2.5 | signal |
| 206 | Osteoarthritis | 38 | 2.5 | 2.5 | signal |
| 207 | Post Procedural Complication | 17 | 2.4 | 2.4 | signal |
| 208 | Skin Lesion | 24 | 2.4 | 2.4 | signal |
| 209 | Fluid Overload | 13 | 2.4 | 2.4 | signal |
| 210 | Liver Disorder | 39 | 2.4 | 2.4 | signal |
| 211 | Circulatory Collapse | 15 | 2.4 | 2.4 | signal |
| 212 | Infection | 124 | 2.4 | 2.4 | signal |
| 213 | Hepatitis | 22 | 2.4 | 2.4 | signal |
| 214 | Hallucination, Visual | 18 | 2.4 | 2.4 | signal |
| 215 | Generalised Tonic-clonic Seizure | 14 | 2.4 | 2.4 | signal |
| 216 | Rash Papular | 19 | 2.3 | 2.3 | signal |
| 217 | Wheezing | 50 | 2.3 | 2.3 | signal |
| 218 | Lactic Acidosis | 27 | 2.3 | 2.3 | signal |
| 219 | Inflammation | 43 | 2.3 | 2.3 | signal |
| 220 | Body Temperature Increased | 17 | 2.3 | 2.3 | signal |
| 221 | Nervous System Disorder | 26 | 2.3 | 2.3 | signal |
| 222 | Infusion Related Reaction | 54 | 2.2 | 2.3 | signal |
| 223 | Chills | 95 | 2.2 | 2.2 | signal |
| 224 | Oral Pain | 18 | 2.2 | 2.2 | signal |
| 225 | Respiratory Disorder | 24 | 2.2 | 2.2 | signal |
| 226 | Rash Generalised | 21 | 2.2 | 2.2 | signal |
| 227 | Mania | 13 | 2.2 | 2.2 | signal |
| 228 | Off Label Use | 682 | 2.2 | 2.3 | signal |
| 229 | Impaired Gastric Emptying | 10 | 2.2 | 2.2 | signal |
| 230 | Neutrophil Count Increased | 8 | 2.1 | 2.1 | no signal |
| 231 | Incorrect Route Of Product Administration | 13 | 2.1 | 2.1 | signal |
| 232 | Ventricular Extrasystoles | 8 | 2.1 | 2.1 | no signal |
| 233 | Haematoma | 20 | 2.1 | 2.1 | signal |
| 234 | Haemoglobin Decreased | 79 | 2.1 | 2.1 | signal |
| 235 | Face Oedema | 13 | 2.1 | 2.1 | signal |
| 236 | Depressed Level Of Consciousness | 30 | 2.1 | 2.1 | signal |
| 237 | Anaphylactic Reaction | 41 | 2.1 | 2.1 | signal |
| 238 | Skin Exfoliation | 62 | 2.1 | 2.1 | signal |
| 239 | Nephropathy | 7 | 2.0 | 2.1 | no signal |
| 240 | Glomerular Filtration Rate Decreased | 9 | 2.0 | 2.0 | no signal |
| 241 | Wound Infection | 8 | 2.0 | 2.0 | no signal |
| 242 | Cellulitis | 37 | 2.0 | 2.0 | signal |
| 243 | Small Intestinal Obstruction | 9 | 2.0 | 2.0 | no signal |
| 244 | General Physical Health Deterioration | 84 | 2.0 | 2.0 | signal |
| 245 | Treatment Failure | 60 | 2.0 | 2.0 | signal |
| 246 | Neuropathy Peripheral | 69 | 2.0 | 2.0 | signal |
| 247 | Deafness | 19 | 2.0 | 2.0 | no signal |
| 248 | Pulmonary Hypertension | 15 | 2.0 | 2.0 | no signal |
| 249 | Muscle Atrophy | 9 | 2.0 | 2.0 | no signal |
| 250 | Bradycardia | 38 | 2.0 | 2.0 | no signal |
| 251 | Blood Test Abnormal | 10 | 2.0 | 2.0 | no signal |
| 252 | Therapeutic Product Effect Incomplete | 50 | 1.9 | 1.9 | no signal |
| 253 | Mitral Valve Incompetence | 8 | 1.9 | 1.9 | no signal |
| 254 | Gastrointestinal Haemorrhage | 59 | 1.9 | 1.9 | no signal |
| 255 | Gastrointestinal Disorder | 62 | 1.9 | 1.9 | no signal |
| 256 | Salivary Hypersecretion | 7 | 1.9 | 1.9 | no signal |
| 257 | Hepatic Steatosis | 13 | 1.9 | 1.9 | no signal |
| 258 | Aphasia | 21 | 1.9 | 1.9 | no signal |
| 259 | Hypothyroidism | 22 | 1.9 | 1.9 | no signal |
| 260 | Pulmonary Congestion | 9 | 1.9 | 1.9 | no signal |
| 261 | Disease Recurrence | 32 | 1.8 | 1.8 | no signal |
| 262 | Product Use In Unapproved Indication | 162 | 1.8 | 1.8 | no signal |
| 263 | Drug Ineffective | 870 | 1.8 | 1.9 | no signal |
| 264 | Epilepsy | 20 | 1.8 | 1.8 | no signal |
| 265 | Disorientation | 26 | 1.8 | 1.8 | no signal |
| 266 | Cerebral Infarction | 16 | 1.8 | 1.8 | no signal |
| 267 | Conjunctivitis | 12 | 1.8 | 1.8 | no signal |
| 268 | Urosepsis | 6 | 1.8 | 1.8 | no signal |
| 269 | Oxygen Saturation Decreased | 36 | 1.8 | 1.8 | no signal |
| 270 | Cardiomegaly | 8 | 1.8 | 1.8 | no signal |
| 271 | Ocular Discomfort | 7 | 1.8 | 1.8 | no signal |
| 272 | Erythema Multiforme | 6 | 1.8 | 1.8 | no signal |
| 273 | Colitis | 24 | 1.8 | 1.8 | no signal |
| 274 | Confusional State | 103 | 1.7 | 1.8 | no signal |
| 275 | Oedema Peripheral | 77 | 1.7 | 1.7 | no signal |
| 276 | Skin Infection | 7 | 1.7 | 1.7 | no signal |
| 277 | Toxicity To Various Agents | 105 | 1.7 | 1.7 | no signal |
| 278 | Intestinal Perforation | 7 | 1.7 | 1.7 | no signal |
| 279 | Rebound Effect | 7 | 1.7 | 1.7 | no signal |
| 280 | Blindness | 25 | 1.7 | 1.7 | no signal |
| 281 | Myocardial Ischaemia | 7 | 1.7 | 1.7 | no signal |
| 282 | Synovitis | 11 | 1.7 | 1.7 | no signal |
| 283 | Gastric Haemorrhage | 7 | 1.7 | 1.7 | no signal |
| 284 | Convulsion | 35 | 1.7 | 1.7 | no signal |
| 285 | Upper Gastrointestinal Haemorrhage | 10 | 1.6 | 1.6 | no signal |
| 286 | Hypophagia | 15 | 1.6 | 1.6 | no signal |
| 287 | Night Sweats | 19 | 1.6 | 1.6 | no signal |
| 288 | Haematemesis | 15 | 1.6 | 1.6 | no signal |
| 289 | Hallucination | 44 | 1.6 | 1.6 | no signal |
| 290 | Gingival Bleeding | 8 | 1.6 | 1.6 | no signal |
| 291 | Osteoporosis | 24 | 1.6 | 1.6 | no signal |
| 292 | Tooth Disorder | 13 | 1.6 | 1.6 | no signal |
| 293 | Lymphoma | 9 | 1.6 | 1.6 | no signal |
| 294 | Respiratory Tract Infection | 15 | 1.6 | 1.6 | no signal |
| 295 | Neuralgia | 14 | 1.6 | 1.6 | no signal |
| 296 | Abdominal Pain | 134 | 1.6 | 1.6 | no signal |
| 297 | Atrial Fibrillation | 56 | 1.6 | 1.6 | no signal |
| 298 | Glaucoma | 11 | 1.6 | 1.6 | no signal |
| 299 | Gastritis | 15 | 1.6 | 1.6 | no signal |
| 300 | Swelling Face | 37 | 1.6 | 1.6 | no signal |
| 301 | Anhedonia | 15 | 1.6 | 1.6 | no signal |
| 302 | Oral Herpes | 11 | 1.6 | 1.6 | no signal |
| 303 | Lymphadenopathy | 20 | 1.6 | 1.6 | no signal |
| 304 | Red Blood Cell Count Decreased | 16 | 1.5 | 1.5 | no signal |
| 305 | Heart Rate Increased | 55 | 1.5 | 1.5 | no signal |
| 306 | Influenza | 62 | 1.5 | 1.5 | no signal |
| 307 | Faeces Discoloured | 12 | 1.5 | 1.5 | no signal |
| 308 | Rhabdomyolysis | 23 | 1.5 | 1.5 | no signal |
| 309 | Product Use Issue | 103 | 1.5 | 1.5 | no signal |
| 310 | White Blood Cell Count Increased | 21 | 1.5 | 1.5 | no signal |
| 311 | Tuberculosis | 7 | 1.5 | 1.5 | no signal |
| 312 | Unresponsive To Stimuli | 14 | 1.5 | 1.5 | no signal |
| 313 | Psychomotor Hyperactivity | 9 | 1.5 | 1.5 | no signal |
| 314 | Appendicitis | 5 | 1.5 | 1.5 | no signal |
| 315 | Anorexia | 7 | 1.5 | 1.5 | no signal |
| 316 | Therapy Partial Responder | 8 | 1.5 | 1.5 | no signal |
| 317 | International Normalised Ratio Increased | 15 | 1.4 | 1.4 | no signal |
| 318 | Dehydration | 69 | 1.4 | 1.4 | no signal |
| 319 | Rash Macular | 18 | 1.4 | 1.4 | no signal |
| 320 | Vasculitis | 6 | 1.4 | 1.4 | no signal |
| 321 | Skin Disorder | 17 | 1.4 | 1.4 | no signal |
| 322 | Bronchitis | 38 | 1.4 | 1.4 | no signal |
| 323 | Neuroleptic Malignant Syndrome | 6 | 1.4 | 1.4 | no signal |
| 324 | Polyneuropathy | 6 | 1.4 | 1.4 | no signal |
| 325 | Feeding Disorder | 10 | 1.4 | 1.4 | no signal |
| 326 | Maternal Exposure During Pregnancy | 44 | 1.4 | 1.4 | no signal |
| 327 | Brain Injury | 5 | 1.4 | 1.4 | no signal |
| 328 | Ovarian Cyst | 5 | 1.4 | 1.4 | no signal |
| 329 | Drug Hypersensitivity | 96 | 1.4 | 1.4 | no signal |
| 330 | Product Prescribing Issue | 10 | 1.3 | 1.4 | no signal |
| 331 | Inappropriate Antidiuretic Hormone Secretion | 5 | 1.3 | 1.3 | no signal |
| 332 | Subarachnoid Haemorrhage | 5 | 1.3 | 1.3 | no signal |
| 333 | Poor Quality Product Administered | 5 | 1.3 | 1.3 | no signal |
| 334 | Cholelithiasis | 16 | 1.3 | 1.3 | no signal |
| 335 | Arrhythmia | 23 | 1.3 | 1.3 | no signal |
| 336 | Rash Pruritic | 26 | 1.3 | 1.3 | no signal |
| 337 | Proteinuria | 9 | 1.3 | 1.3 | no signal |
| 338 | Chronic Kidney Disease | 36 | 1.3 | 1.3 | no signal |
| 339 | Mydriasis | 6 | 1.3 | 1.3 | no signal |
| 340 | Breast Cancer Metastatic | 5 | 1.3 | 1.3 | no signal |
| 341 | Paranoia | 8 | 1.3 | 1.3 | no signal |
| 342 | Diabetic Ketoacidosis | 11 | 1.3 | 1.3 | no signal |
| 343 | Tooth Fracture | 5 | 1.2 | 1.2 | no signal |
| 344 | Angioedema | 20 | 1.2 | 1.2 | no signal |
| 345 | Dental Caries | 5 | 1.2 | 1.2 | no signal |
| 346 | Cardio-respiratory Arrest | 19 | 1.2 | 1.2 | no signal |
| 347 | Exposure During Pregnancy | 28 | 1.2 | 1.2 | no signal |
| 348 | Hypersensitivity | 83 | 1.2 | 1.2 | no signal |
| 349 | Cerebral Haemorrhage | 16 | 1.2 | 1.2 | no signal |
| 350 | Blood Creatine Phosphokinase Increased | 13 | 1.2 | 1.2 | no signal |
| 351 | Chromaturia | 10 | 1.2 | 1.2 | no signal |
| 352 | Myocarditis | 5 | 1.2 | 1.2 | no signal |
| 353 | Pallor | 12 | 1.2 | 1.2 | no signal |
| 354 | Eyelid Oedema | 5 | 1.2 | 1.2 | no signal |
| 355 | Deformity | 4 | 1.2 | 1.2 | no signal |
| 356 | Blindness Unilateral | 6 | 1.2 | 1.2 | no signal |
| 357 | Product Prescribing Error | 10 | 1.2 | 1.2 | no signal |
| 358 | Pericarditis | 7 | 1.2 | 1.2 | no signal |
| 359 | Skin Haemorrhage | 6 | 1.1 | 1.1 | no signal |
| 360 | Tooth Extraction | 5 | 1.1 | 1.1 | no signal |
| 361 | Intestinal Obstruction | 15 | 1.1 | 1.1 | no signal |
| 362 | Hypoacusis | 17 | 1.1 | 1.1 | no signal |
| 363 | Thirst | 7 | 1.1 | 1.1 | no signal |
| 364 | Osteonecrosis | 13 | 1.1 | 1.1 | no signal |
| 365 | Gallbladder Disorder | 7 | 1.1 | 1.1 | no signal |
| 366 | Economic Problem | 6 | 1.1 | 1.1 | no signal |
| 367 | Tooth Infection | 5 | 1.0 | 1.0 | no signal |
| 368 | Respiratory Arrest | 10 | 1.0 | 1.0 | no signal |
| 369 | Myelodysplastic Syndrome | 5 | 0.9 | 0.9 | no signal |
| 370 | Caesarean Section | 4 | 0.9 | 0.9 | no signal |
| 371 | Rheumatoid Arthritis | 38 | 0.9 | 0.9 | no signal |
| 372 | Tooth Loss | 7 | 0.9 | 0.9 | no signal |
| 373 | Osteonecrosis Of Jaw | 8 | 0.9 | 0.9 | no signal |
| 374 | Grand Mal Convulsion | 3 | 0.9 | 0.9 | no signal |
| 375 | Leukaemia | 3 | 0.9 | 0.9 | no signal |
| 376 | Metastases To Central Nervous System | 4 | 0.9 | 0.9 | no signal |
| 377 | Decreased Immune Responsiveness | 3 | 0.8 | 0.8 | no signal |
| 378 | Abnormal Behaviour | 12 | 0.8 | 0.8 | no signal |
| 379 | Haemorrhage | 31 | 0.8 | 0.8 | no signal |
| 380 | Metastases To Liver | 5 | 0.8 | 0.8 | no signal |
| 381 | Systemic Lupus Erythematosus | 10 | 0.8 | 0.8 | no signal |
| 382 | Malignant Neoplasm Progression | 28 | 0.8 | 0.8 | no signal |
| 383 | Metastases To Lung | 3 | 0.7 | 0.7 | no signal |
| 384 | Colitis Ulcerative | 11 | 0.7 | 0.7 | no signal |
| 385 | Hepatitis C | 3 | 0.7 | 0.7 | no signal |
| 386 | Metastases To Bone | 4 | 0.7 | 0.7 | no signal |
| 387 | Plasma Cell Myeloma | 9 | 0.6 | 0.6 | no signal |
| 388 | Complication Associated With Device | 3 | 0.6 | 0.6 | no signal |
| 389 | Overdose | 48 | 0.6 | 0.6 | no signal |
| 390 | Bone Density Decreased | 7 | 0.6 | 0.6 | no signal |
| 391 | Incorrect Route Of Drug Administration | 8 | 0.6 | 0.6 | no signal |
| 392 | Blood Glucose Decreased | 10 | 0.6 | 0.6 | no signal |
| 393 | Drug Effective For Unapproved Indication | 6 | 0.6 | 0.6 | no signal |
| 394 | Neoplasm Progression | 7 | 0.5 | 0.5 | no signal |
| 395 | Extrapyramidal Disorder | 5 | 0.5 | 0.5 | no signal |
| 396 | Device Failure | 3 | 0.5 | 0.5 | no signal |
| 397 | Bone Loss | 3 | 0.5 | 0.5 | no signal |
| 398 | Multiple Fractures | 3 | 0.5 | 0.5 | no signal |
| 399 | Abortion Spontaneous | 7 | 0.5 | 0.5 | no signal |
| 400 | Palmar-plantar Erythrodysaesthesia Syndrome | 4 | 0.5 | 0.5 | no signal |
| 401 | Dystonia | 3 | 0.4 | 0.4 | no signal |
| 402 | Drug Prescribing Error | 3 | 0.4 | 0.4 | no signal |
| 403 | Drug Exposure During Pregnancy | 5 | 0.4 | 0.4 | no signal |
| 404 | Tardive Dyskinesia | 4 | 0.4 | 0.4 | no signal |
| 405 | Drug Withdrawal Syndrome | 11 | 0.3 | 0.3 | no signal |
| 406 | Pharmaceutical Product Complaint | 3 | 0.3 | 0.3 | no signal |